Assessing the heterogeneity of treatment effects within subgroups
The forthcoming Subgroup Screening report within JMP Clinical 19 is a straightforward way to assess how the treatment effect (or the treatment response, in the case of single-arm studies) for a particular endpoint can vary across subgroups and which factors might contribute to this heterogeneity.